BlackRock Health Sciences Term Trust EBIT

The latest EBIT for BMEZ is $44M as of December 2024. That is above the sector sector average of $-9.6M. Investors often review this figure alongside BlackRock Health Sciences Term Trust's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, BMEZ currently prints $44M for EBIT, while the sector average sits near $-9.6M. That is roughly 551.9% above the sector mean. Large gaps often invite a closer look at BlackRock Health Sciences Term Trust's growth, margins, and balance sheet.

A EBIT figure of $44M for BMEZ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-9.6M. Explore the charts below for those layers of context.

After noting BMEZ's EBIT ($44M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.